Keywords: aspreva, roche, cellcept, gains, orphan, status, canadian

Aspreva and Roche's CellCept gains orphan status

Article | 09 January 2006

Print This

Canadian drugmaker Aspreva and Swiss pharmaceutical major Roche say that the US Food and Drug Administration has granted Orphan Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in